Abstract
CP-66,948 is a histamine H2-receptor antagonist with gastric antisecretory activity and mucosal protective properties. The affinity of CP-66,948 for the guinea pig atria histamine H2-receptor is 15 times greater than that of cimetidine and seven times greater than that of ranitidine.In vivo, the ED50 value for inhibition of gastric acid secretion in pylorusligated rats is 2 mg/kg intraduodenally, and in histamine or pentagastrin-stimulated Heidenhain pouch dogs the antisecretory ED50 values are 0.3 mg/kgper os and 1.0 mg/kgper os, respectively. CP-66,948 also inhibits ethanol-induced gastric hemorrhagic lesions in rats following either oral or systemic administration (ED50 values of 12 mg/kgper os and 6 mg/kg subcutaneously). In addition, the mucosal protective activity is independent of prostaglandin synthesis. CP-66,948 inhibits gastric acid secretion in man, and its mucosal protective activity may provide additional benefits in peptic ulcer therapy.
Similar content being viewed by others
References
Robert A, Nezamis JE, Lancaster C, Hanchar AJ: Cytoprotection by prostaglandin in rats. Prevention of gastric necrosis produced by alcohol, HCl, NaOH, hypertonic NaCl, and thermal injury. Gastroenterology 77:433–443, 1979
Lacy ER, Ito S: Microscopic analysis of ethanol damage to rat gastric mucosa after treatment with a prostaglandin. Gastroenterology 83:619–625, 1982
Arunlakshana O, Schild HO: Some quantitative uses of drug antagonists. Br J Pharmacol 14:48–58, 1959
DeVito RV, Harkins HN: Techniques in Heidenhain pouch experiments. J Appl Physiol 14:138–139, 1959
Oates PJ, Hakkinen JP: Studies on the mechanism of ethanol-induced gastric damage in rats. Gastroenterology 94:10–21, 1988
Moncada S, Salmon JA, Vane JR, Whittle BJR: Formation of prostacyclin and its product 6-oxo-PGF1α by the gastric mucosa of several species. J Physiol 275:4P-5P, 1978
Black JW, Duncan WAM, Durant CJ, Ganellin CR, Parsons EM: Definition and antagonism of histamine H2-receptors. Nature 236:385–390, 1972
Daly MJ, Humphray JM, Stables R: Some in vitro and in vivo actions of the new histamine H2-receptor antagonist, ranitidine. Br J Pharmacol 72:49–54, 1981
Cavanagh RL, Usakewicz JJ, Buyniski JP: A comparison of some of the pharmacological properties of etintidine, a new histamine H2-receptor antagonist, with those of cimetidine, ranitidine, and tiotidine. J Pharmacol Exp Ther 224:171–179, 1983
Konturek SJ, Radecki T, Brzozowski T, Piastucki I, Dembinska-Kiec A, Zmuda A: Gastric cytoprotection by prostaglandins, ranitidine, and probanthine in rats. Role of endogenous prostaglandins. Scand J Gastroenterol 16:7–12, 1981
Guth PH, Aures D, Paulsen G: Topical aspirin plus HCl gastric lesions in the rat. Cytoprotective effect of prostaglandin, cimetidine, and probanthine. Gastroenterology 76:88–93, 1979
Robert A, Lancaster C, Davis JP, Field SO, Nezamis JE: Distinction between antiulcer effect and cytoprotection. Scand J Gastroenterol 19(suppl 101):69–72, 1984
Tarnawski A, Stachura J, Ivey KJ, Mach T: Cimetidine and ranitidine increase ethanol-induced gastric mucosal damage in rat and partially abolish prostaglandin “cytoprotection”. Gastroenterology 80:1300, 1980 (abstract)
Puurunen J: Effect of prostaglandin E2, cimetidine, and atropine on ethanol-induced gastric mucosal damage in the rat. Scand J Gastroenterol 15:485–488, 1980
Del Soldato P, Foschi D, Varin L, Daniotti S: Comparison of the gastric cytoprotective properties of atropine, ranitidine, and PGE2 in rats. Eur J Pharmacol 106:53–58, 1985
Robert A, Nezamis JE, Lancaster C, Davis JP, Field SO, Hanchar J: Mild irritants prevent gastric necrosis through “adaptive cytoprotection” mediated by prostaglandins. Am J Physiol 245:G113-G121, 1983
Konturek SJ, Brzozowski T, Piastucki I, Radecki T, Dembinski A, Dembinske-Kiec A: Role of locally generated prostaglandins in adaptive gastric cytoprotection. Dig Dis Sci 27:967–971, 1982
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hakkinen, J.P., Holt, W.F., Goddard, C.J. et al. CP-66,948: An antisecretory histamine H2-receptor antagonist with mucosal protective properties. Digest Dis Sci 36, 1721–1728 (1991). https://doi.org/10.1007/BF01296616
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01296616